MN
Mandapakala Neelalohita
About Mandapakala Neelalohita
Data last updated:
Mandapakala Neelalohita is a Company Secretary at Kmvpl Raipur-Visakhapatnam Highway Private Limited (since 2024), Director at Satyadeeptha Pharmaceuticals Limited (since 2025) and Director at Hemair Systems India Limited (since 2025). The companies operate in Infrastructure and Utilities, Pharma and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹487 Cr; the largest is Kmvpl Raipur-Visakhapatnam Highway Private Limited at ₹257 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 21 Oct 2024 | 2022 | ₹257 Cr (FY 2025) | Active | |
| Director | 30 Sep 2025 | 1987 | ₹139 Cr (FY 2025) | Active | |
| Director | 30 Sep 2025 | 1996 | ₹91.01 Cr (FY 2024) | Active |
Board colleagues of Mandapakala Neelalohita
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mandapakala Neelalohita
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandapakala Neelalohita
Mandapakala Neelalohita currently holds 3 directorships: Kmvpl Raipur-Visakhapatnam Highway Private Limited (Company Secretary, since 21 Oct 2024, revenue ₹257 Cr (FY 2025)); Satyadeeptha Pharmaceuticals Limited (Director, since 30 Sep 2025, revenue ₹139 Cr (FY 2025)); Hemair Systems India Limited (Director, since 30 Sep 2025, revenue ₹91.01 Cr (FY 2024)).
Mandapakala Neelalohita was first appointed on 21 Oct 2024 as Company Secretary at Kmvpl Raipur-Visakhapatnam Highway Private Limited. The most recent appointment on record is 30 Sep 2025 at Hemair Systems India Limited.
The 3 current companies of Mandapakala Neelalohita that report revenue have a combined latest revenue of ₹487 Cr: Kmvpl Raipur-Visakhapatnam Highway Private Limited ₹257 Cr (FY 2025); Satyadeeptha Pharmaceuticals Limited ₹139 Cr (FY 2025); Hemair Systems India Limited ₹91.01 Cr (FY 2024).
The current boards of Mandapakala Neelalohita's companies include Allala Bhasker Reddy (Kmvpl Raipur-Visakhapatnam Highway Private Limited), Arunrakesh Kanakamedala (Kmvpl Raipur-Visakhapatnam Highway Private Limited), Kanakamedala Prudhvi Ram (Kmvpl Raipur-Visakhapatnam Highway Private Limited), Vasanth Kumar Pendurthi (Kmvpl Raipur-Visakhapatnam Highway Private Limited), Prasada Rao Kalluri (Satyadeeptha Pharmaceuticals Limited), Sudheer Kumar Aleti (Satyadeeptha Pharmaceuticals Limited), among others.